These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 27237366)

  • 1. Acute infections, cost and time to reporting of HIV test results in three U.S. State Public Health Laboratories.
    Nasrullah M; Wesolowski LG; Ethridge SF; Cranston K; Pentella M; Myers RA; Rudrik JT; Hutchinson AB; Bennett SB; Werner BG
    J Infect; 2016 Aug; 73(2):164-72. PubMed ID: 27237366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid testing by public health referral laboratories for public health laboratories using the U.S. HIV diagnostic testing algorithm.
    Wesolowski LG; Wroblewski K; Bennett SB; Parker MM; Hagan C; Ethridge SF; Rhodes J; Sullivan TJ; Ignacio-Hernando I; Werner BG; Owen SM
    J Clin Virol; 2015 Apr; 65():6-10. PubMed ID: 25766979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of the new HIV-1/2 diagnostic algorithm in Florida's public health testing population: a review of the first five months of utilization.
    Bennett B; Neumann D; Fordan S; Villaraza R; Crowe S; Gillis L
    J Clin Virol; 2013 Dec; 58 Suppl 1():e29-33. PubMed ID: 24342476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of rapid HIV assays as supplemental tests in specimens with repeatedly reactive screening immunoassay results not confirmed by HIV-1 Western blot.
    Wesolowski LG; Delaney KP; Meyer WA; Blatt AJ; Bennett B; Chavez P; Granade TC; Owen M
    J Clin Virol; 2013 Sep; 58(1):240-4. PubMed ID: 23838670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of a fourth-generation HIV screening assay and an alternative HIV diagnostic testing algorithm.
    Nasrullah M; Wesolowski LG; Meyer WA; Owen SM; Masciotra S; Vorwald C; Becker WJ; Branson BM
    AIDS; 2013 Mar; 27(5):731-7. PubMed ID: 23135170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of supplemental testing with the Multispot HIV-1/HIV-2 Rapid Test and APTIMA HIV-1 RNA Qualitative Assay to resolve specimens with indeterminate or negative HIV-1 Western blots.
    Linley L; Ethridge SF; Oraka E; Owen SM; Wesolowski LG; Wroblewski K; Landgraf KM; Parker MM; Brinson M; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e108-12. PubMed ID: 24342469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three Years of Shared Service HIV Nucleic Acid Testing for Public Health Laboratories: Worthwhile for HIV-1 but Not for HIV-2.
    Styer LM; Gaynor AM; Parker MM; Bennett SB; Wesolowski LG; Ethridge S; Chavez PR; Sullivan TJ; Fordan S; Wroblewski K
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S8-S12. PubMed ID: 31876868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early HIV infections using the fourth generation Abbott ARCHITECT HIV Ag/Ab Combo chemiluminescent microparticle immunoassay (CIA) in San Diego County.
    Manlutac AL; Giesick JS; McVay PA
    J Clin Virol; 2013 Dec; 58 Suppl 1():e44-7. PubMed ID: 24342477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of turnaround time and total cost of HIV testing before and after implementation of the 2014 CDC/APHL Laboratory Testing Algorithm for diagnosis of HIV infection.
    Chen DJ; Yao JD
    J Clin Virol; 2017 Jun; 91():69-72. PubMed ID: 28461133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of an alternative laboratory-based algorithm for diagnosis of HIV infection utilizing a third generation immunoassay, a rapid HIV-1/HIV-2 differentiation test and a DNA or RNA-based nucleic acid amplification test in persons with established HIV-1 infection and blood donors.
    Wesolowski LG; Delaney KP; Hart C; Dawson C; Owen SM; Candal D; Meyer WA; Ethridge SF; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S45-9. PubMed ID: 21995934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and outcomes of laboratory diagnostic algorithms for the detection of HIV.
    Hutchinson AB; Ethridge SF; Wesolowski LG; Shrestha RK; Pentella M; Bennett B; Farnham PG; Sullivan T; Patel P; Branson BM
    J Clin Virol; 2013 Dec; 58 Suppl 1():e2-7. PubMed ID: 24342475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of an alternative laboratory-based algorithm for HIV diagnosis in a high-risk population.
    Delaney KP; Heffelfinger JD; Wesolowski LG; Owen SM; Meyer WA; Kennedy S; Uniyal A; Kerndt PR; Branson BM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S5-10. PubMed ID: 22019251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of missed HIV infections in individuals with indeterminate or negative HIV western blots based on current HIV testing algorithm in China.
    Liu MQ; Zhu ZR; Kong WH; Tang L; Peng JS; Wang X; Xu J; Schilling RF; Cai T; Zhou W
    J Med Virol; 2016 Aug; 88(8):1462-6. PubMed ID: 26856240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative performance of the Geenius™ HIV-1/HIV-2 supplemental test in Florida's public health testing population.
    Fordan S; Bennett B; Lee M; Crowe S
    J Clin Virol; 2017 Jun; 91():79-83. PubMed ID: 28434810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an alternative HIV diagnostic algorithm using specimens from seroconversion panels and persons with established HIV infections.
    Masciotra S; McDougal JS; Feldman J; Sprinkle P; Wesolowski L; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S17-22. PubMed ID: 21981983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Multispot EIA with Western blot for confirmatory serodiagnosis of HIV.
    Torian LV; Forgione LA; Punsalang AE; Pirillo RE; Oleszko WR
    J Clin Virol; 2011 Dec; 52 Suppl 1():S41-4. PubMed ID: 21995935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine HIV Test Results in 6 US Clinical Laboratories Using the Recommended Laboratory HIV Testing Algorithm With Geenius HIV 1/2 Supplemental Assay.
    Wesolowski LG; Chavez PR; Cárdenas AM; Katayev A; Slev P; Valsamakis A; Wang YF; Yao JD; Dougherty C; Gillim-Ross L; Harmon C; Delaney KP
    Sex Transm Dis; 2020 May; 47(5S Suppl 1):S13-S17. PubMed ID: 32343517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of acute infections during HIV testing in North Carolina.
    Pilcher CD; Fiscus SA; Nguyen TQ; Foust E; Wolf L; Williams D; Ashby R; O'Dowd JO; McPherson JT; Stalzer B; Hightow L; Miller WC; Eron JJ; Cohen MS; Leone PA
    N Engl J Med; 2005 May; 352(18):1873-83. PubMed ID: 15872202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the CDC proposed laboratory HIV testing algorithm among men who have sex with men (MSM) from five US metropolitan statistical areas using specimens collected in 2011.
    Masciotra S; Smith AJ; Youngpairoj AS; Sprinkle P; Miles I; Sionean C; Paz-Bailey G; Johnson JA; Owen SM
    J Clin Virol; 2013 Dec; 58 Suppl 1(Suppl 1):e8-e12. PubMed ID: 24342483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4th generation HIV screening in Massachusetts: a partnership between laboratory and program.
    Goodhue T; Kazianis A; Werner BG; Stiles T; Callis BP; Dawn Fukuda H; Cranston K
    J Clin Virol; 2013 Dec; 58 Suppl 1():e13-8. PubMed ID: 24342473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.